Legendary investor Jim Rogers, chairman of Rogers Holdings, is joining the management of South Korean graphene firm Nanomedics. As graphene can be widely used in various fields, it is called the “dream material.”
Nanomedics announced on Aug. 13 that it is planning to appoint Rogers and Standard Graphene CEO Lee Joung-hoon as its executive directors at an extraordinary shareholders meeting on Aug. 30.
Rogers said, “I think Nanomedics and Standard Graphene can turn my interest in graphene into actual business. If I become an executive director at Nanomedics, I will be dedicated to providing continuous support.”
Rogers is considered one of the world's top three investors along with Warren Buffett and George Soros. He became a legend on Wall Street after cofounding global investment company Quantum Fund with George Soros and recording a profit rate of 4,200 percent for a decade.
Nanomedics is the second largest shareholder of Standard Graphene. The company has established a joint venture with Standard Graphene by investing 4 billion won (US$3.27 million) and is preparing production facilities to mass produce graphene. It aims to manufacture 4 tons of graphene a year. Rogers had also made an investment in graphene technology owned by Standard Graphene.
Nanomedics is planning to provide a stock option of 500,000 shares to encourage his active involvement in management when he is appointed as an internal board member. Rogers said, “I currently have a lot of interest in the graphene business, but there is little way to directly jump into the business or separately cooperate with companies. I can achieve the two goals through Nanomedics.”